Revive Therapeutics Ltd (RVVTF)

[hotmeat]

Been watching that since the news about the LOI to sell RVV it's Psilocybin program.

The deal does not seem to include their Ketamine program for treating mental disorders.

The pps has been steadily increasing since early Dec 2020 for no apparent reason. Stock is up 100%+ to date (50%+ since 01/04/2021) on relatively low Vol.



Also of note......

- stock has very recently been designated as a "SHELL RISK" on OTC.com.

- Up-listed to the OTCQB as of 01/04/2021 (RVV still on Pinks???)

- Does not currently have any Note debt per filings with OTC

- Four(4) employees hold senior positions in both companies.

Carmelo Marrelli: CFO

Jay Vieira: Counsel for RVV -- Securities Counsel for PHRFF

Andrew Todd: VP of RVV -- Corp. Secretary of PHRFF

Christian Scovenna: Independent Director/Audit Committee Member



DRAW YOUR OWN CONCLUSIONS

-